Genetic Technologies Ltd
DU8
ISIN AU000000GTG7 / Valor 1124821
Genetic Technologies Ltd
UMushroom community rating:
About company
Genetic Technologies Ltd is a company specializing in the field of genetic risk assessment. Through its geneType brand, the company provides integrated testing services designed to evaluate the risk of developing various serious health conditions. This innovative approach to health management allows individuals to gain insights into their genetic predisposition for diseases, enabling proactive measures for prevention or early intervention. Genetic Technologies Ltd leverages advancements in genetic science to offer these comprehensive risk assessment solutions, aiming to contribute to personalized healthcare and improved patient outcomes.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (13.06.2024):
Revenue Decline
In the first half of FY2024, Genetic Technologies Ltd reported a revenue of 3.96 million AUD, which represents a decrease of 4.70% compared to the previous year. This decline highlights challenges in the market or operational areas.
Earnings Per Share Increase
Despite the revenue decline, Genetic Technologies Ltd experienced an increase in earnings per share (EPS) by 7.33% year-over-year. This improvement in EPS suggests a better cost management or operational efficiency during the period.
No Dividend Information
There is no available data regarding dividends for Genetic Technologies Ltd for the first half of FY2024. This could indicate that the company has not declared any dividends during this period.
Market Performance
As of the latest update, Genetic Technologies Ltd's stock price saw a slight increase of 2.17%, reflecting a market adjustment possibly in response to the company's earnings results or other external factors influencing investor sentiment.
Future Outlook Unclear
There is no specific outlook provided for the future financial performance of Genetic Technologies Ltd. This absence of guidance might contribute to uncertainty among investors regarding the company's future direction.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
12 M
Market cap (USD)
300
Daily traded volume (Shares)
0.019 / 0.019
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
